What is the official website of Gilead Sciences UK & Ireland ?

The official website of Gilead Sciences UK & Ireland is https://www.gilead.co.uk/.

What is Gilead Sciences UK & Ireland's cybersecurity risk score?

Gilead Sciences UK & Ireland has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Gilead Sciences UK & Ireland experienced?

According to Rankiteo, Gilead Sciences UK & Ireland currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Gilead Sciences UK & Ireland been affected by any supply chain cyber incidents ?

According to Rankiteo, Gilead Sciences UK & Ireland has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Gilead Sciences UK & Ireland have SOC 2 Type 1 certification ?

According to Rankiteo, Gilead Sciences UK & Ireland is not certified under SOC 2 Type 1.

Does Gilead Sciences UK & Ireland have SOC 2 Type 2 certification ?

According to Rankiteo, Gilead Sciences UK & Ireland does not hold a SOC 2 Type 2 certification.

Does Gilead Sciences UK & Ireland comply with GDPR ?

According to Rankiteo, Gilead Sciences UK & Ireland is not listed as GDPR compliant.

Does Gilead Sciences UK & Ireland have PCI DSS certification ?

According to Rankiteo, Gilead Sciences UK & Ireland does not currently maintain PCI DSS compliance.

Does Gilead Sciences UK & Ireland comply with HIPAA ?

According to Rankiteo, Gilead Sciences UK & Ireland is not compliant with HIPAA regulations.

Does Gilead Sciences UK & Ireland have ISO 27001 certification ?

According to Rankiteo,Gilead Sciences UK & Ireland is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Gilead Sciences UK & Ireland operate in ?

Gilead Sciences UK & Ireland operates primarily in the Biotechnology Research industry.

How many employees does Gilead Sciences UK & Ireland have ?

Gilead Sciences UK & Ireland employs approximately None employees people worldwide.

Does Gilead Sciences UK & Ireland own any subsidiaries ?

Gilead Sciences UK & Ireland presently has no subsidiaries across any sectors.

How many LinkedIn followers does Gilead Sciences UK & Ireland have ?

Gilead Sciences UK & Ireland's official LinkedIn profile has approximately 3,208 followers.

What is the NAICS classification code for Gilead Sciences UK & Ireland ?

Gilead Sciences UK & Ireland is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Gilead Sciences UK & Ireland have a Crunchbase profile ?

No, Gilead Sciences UK & Ireland does not have a profile on Crunchbase.

Does Gilead Sciences UK & Ireland have a LinkedIn profile ?

Yes, Gilead Sciences UK & Ireland maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/gilead-uk-ireland.

How many cybersecurity incidents has Gilead Sciences UK & Ireland experienced ?

As of July 6, 2026, Rankiteo reports that Gilead Sciences UK & Ireland has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Gilead Sciences UK & Ireland have ?

Gilead Sciences UK & Ireland has an estimated 4,715 peer or competitor companies worldwide.

What types of cybersecurity incidents has Gilead Sciences UK & Ireland faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

GSUI

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

Gilead Sciences UK & Ireland Vendor Cyber Rating & Cyber Score

gilead.co.uk

Add Your Compliance Badge

At Gilead, we set bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives.

GSUI A.I CyberSecurity Scoring

Scoring History

GSUI

Gilead Sciences UK & Ireland CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Gilead Sciences UK ...

Breach

2/2025

GIL957091725

Gilead Sciences UK ...

Cyber Attack

05/2020

GIL1527222

Loading…

A.I.

GSUI Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for GSUI

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Gilead Sciences UK & Ireland in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Gilead Sciences UK & Ireland in 2026.

Incident Types GSUI vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Gilead Sciences UK & Ireland in 2026.

Incident History - GSUI (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Gilead Sciences UK & Ireland Subsidiaries

GSUI

Biotechnology Research

Website: https://www.gilead.co.uk/

Company Size: 1,001-5,000 employees

Gilead SciencesBiotechnology Research

Gilead OncologyBiotechnology Research

Gilead Sciences CanadaBiotechnology Research

Gilead Sciences FranceBiotechnology Research

Gilead Sciences AustraliaBiotechnology Research

Loading…

Gilead Sciences UK & Ireland Similar Companies

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Agilent Technologies

cb agilent.com

Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Loading…

NEWS

Gilead Sciences UK & Ireland CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 22, 2025 08:00 AM

UK approves Gilead’s twice-yearly HIV PrEP drug

Gilead Sciences' pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option for HIV,...

Read Article

December 19, 2025 08:00 AM

Gilead Sciences Stock (GILD) After Hours on Dec. 19, 2025: TrumpRx Pricing Deal, UK Lenacapavir Approval, and What to Watch Before the Next Market Open

Gilead Sciences Stock (GILD) After Hours on Dec. 19, 2025: TrumpRx Pricing Deal, UK Lenacapavir Approval, and What to Watch Before the Next...

Read Article

October 14, 2025 07:00 AM

Chinese Research Body Says Gilead Infringed COVID Patent

A Chinese military medical research institute has accused Gilead at a London court of infringing its patent for a COVID-19 treatment,...

Read Article

September 09, 2025 07:00 AM

Ending the HIV epidemic by 2030

New modelling by Gilead Sciences shows we're off-track to meet current targets - but hope is not lost.

Read Article

August 23, 2025 07:00 AM

‘Precious’ breast cancer drug withheld from NHS in price row

The pharma giant Gilead Sciences will not send Trodelvy for assessment by the UK drugs watchdog, claiming it can't make enough profit in...

Read Article

July 11, 2025 07:00 AM

Gilead Campaign Aims to Close HIV Gender Gap in UK

The United Kingdom has made significant strides in tackling HIV, however a gender gap in care still exists. Women make up a third of the...

Read Article

June 24, 2025 07:21 PM

From the Margins

From the Margins tells the stories of six remarkable people. Their words tell tales of hardship, discrimination, and injustice. Learn more.

Read Article

June 24, 2025 07:21 PM

‘Unseen Unheard: The untold breast cancer stories of Black women in the UK’

This pioneering, award winning theatre project, commissioned by Gilead Sciences Ltd and developed in collaboration with Black Women Rising,...

Read Article

June 04, 2025 07:00 AM

The UK must act to stem £11 billion loss to health research

The UK could lose out on £11 billion in pharmaceuticals research and development (R&D) investment by 2033, and see fewer new medicine...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-14776

SUMMARY

A security flaw has been discovered in SourceCodester Onlne Examination & Learning Management System 1.0. Affected by this vulnerability is the function pathinfo of the file /upload_files.php of the component Filename Extension. Performing a manipulation results in unrestricted upload. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks. The name of the affected product appears to have a typo in it.

Published

Date2026-07-05

Updated

Date2026-07-05

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-14775

SUMMARY

A vulnerability was identified in SourceCodester Onlne Examination & Learning Management System 1.0. Affected is an unknown function of the file /process_lesson.php. Such manipulation of the argument user_id leads to unrestricted upload. The attack may be launched remotely. The exploit is publicly available and might be used. The name of the affected product appears to have a typo in it.

Published

Date2026-07-05

Updated

Date2026-07-05

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-14774

SUMMARY

A vulnerability was determined in itsourcecode Hospital Management System 1.0. This impacts an unknown function of the file /paymentdischarge.php. This manipulation of the argument patientid causes sql injection. The attack may be initiated remotely. The exploit has been publicly disclosed and may be utilized.

Published

Date2026-07-05

Updated

Date2026-07-05

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-14773

SUMMARY

A vulnerability was found in itsourcecode Hospital Management System 1.0. This affects an unknown function of the file /payment.php. The manipulation of the argument patientid results in sql injection. The attack can be launched remotely. The exploit has been made public and could be used.

Published

Date2026-07-05

Updated

Date2026-07-05

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-10657

SUMMARY

Zephyr's DNS resolver detects mDNS (.local) queries in dns_resolve_name_internal() (subsys/net/lib/dns/resolve.c) with memcmp(strrchr(query, '.'), ".local", 7), which always reads a fixed 7 bytes from the suffix pointer. When the resolved hostname's final label is shorter than 7 bytes (e.g. names ending in .org, .com, .net, .io, or a trailing dot), the comparison reads 1-2 bytes past the string's NUL terminator. The hostname (query) is the caller-supplied name passed through the standard getaddrinfo()/dns_get_addr_info()/dns_resolve_name() path and is influenceable by operators or remote inputs (server names from configuration, parsed URLs, or app-facing interfaces). On a tightly-sized buffer with no slack (for example a userspace getaddrinfo call where the hostname is copied with k_usermode_string_alloc_copy to exactly strlen+1 bytes), the over-read crosses the allocation boundary; if that boundary is unmapped (guard page, memory-domain boundary under MPU, or an address sanitizer) the over-read faults, causing a denial of service. The over-read bytes are never returned, so there is no information disclosure. The flaw is compiled only when CONFIG_MDNS_RESOLVER is enabled, exists since v1.10.0, and is fixed by replacing the fixed-length memcmp with a NUL-safe strcmp(ptr, ".local").

Published

Date2026-07-05

Updated

Date2026-07-05

RISK INFORMATION (Score: 3.7)

cvss3

Base Score: 3.7

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

2.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…